ARMP Long Call Strategy
ARMP (Armata Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on AMEX.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
ARMP (Armata Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $323.1M, a beta of 1.32 versus the broader market, a 52-week range of 1.17-16.34, average daily share volume of 56K, a public-listing history dating back to 1994, approximately 60 full-time employees. These structural characteristics shape how ARMP stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.32 indicates ARMP has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on ARMP?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current ARMP snapshot
As of May 15, 2026, spot at $8.05, ATM IV 209.80%, IV rank 38.08%, expected move 60.15%. The long call on ARMP below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on ARMP specifically: ARMP IV at 209.80% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 60.15% (roughly $4.84 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ARMP expiries trade a higher absolute premium for lower per-day decay. Position sizing on ARMP should anchor to the underlying notional of $8.05 per share and to the trader's directional view on ARMP stock.
ARMP long call setup
The ARMP long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ARMP near $8.05, the first option leg uses a $8.05 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ARMP chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ARMP shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $8.05 | N/A |
ARMP long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ARMP long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ARMP. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ARMP
Long calls on ARMP express a bullish thesis with defined risk; traders use them ahead of ARMP catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ARMP thesis for this long call
The market-implied 1-standard-deviation range for ARMP extends from approximately $3.21 on the downside to $12.89 on the upside. A ARMP long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ARMP IV rank near 38.08% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ARMP should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ARMP options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ARMP-specific events.
ARMP long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ARMP positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ARMP alongside the broader basket even when ARMP-specific fundamentals are unchanged. Long-premium structures like a long call on ARMP are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ARMP chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ARMP?
- A long call on ARMP is the long call strategy applied to ARMP (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ARMP stock trading near $8.05, the strikes shown on this page are snapped to the nearest listed ARMP chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ARMP long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ARMP long call priced from the end-of-day chain at a 30-day expiry (ATM IV 209.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ARMP long call?
- The breakeven for the ARMP long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ARMP market-implied 1-standard-deviation expected move is approximately 60.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ARMP?
- Long calls on ARMP express a bullish thesis with defined risk; traders use them ahead of ARMP catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ARMP implied volatility affect this long call?
- ARMP ATM IV is at 209.80% with IV rank near 38.08%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.